Verified peer comparison

Katapult Holdings vs Xeris Biopharma Holdings Financial Comparison

Direct answer

Katapult Holdings and Xeris Biopharma Holdings are compared on the same basis.

The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage

Get free Katapult Holdings email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Katapult Holdings Revenue
291,761,000 USD
Xeris Biopharma Holdings Revenue
291,845,000 USD
Katapult Holdings Operating income
300,000 USD
Xeris Biopharma Holdings Operating income
24,896,000 USD